The Borlaug Report #5: Catalent

Let Them Cook.

Introduction

With both parts of my bioprocessing primer out of the way, and enough news flow to make any company a battleground stock, it’s time to talk about Catalent. 

Catalent is a CDMO that has evolved a lot since it went public around a decade ago. From 2013-2019, the company grew ~6% annualized, which at the surface is rather unimpressive. However, …